Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 14 Oct 2021

GSTT1null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients

in Hematologic Malignancies

Shahid M. Baba
Arshad A. Pandith
Zafar A. Shah
Sajad A. Geelani
Javid R. Bhat
Ayaz Gul
Sameer A. Guru
Hamed A. El-Serehy
Abid M. Koul
Sheikh Mansoor

Frontiers in Oncology

doi 10.3389/fonc.2021.714421

4,749 views
8 citations

Clinical Trial

Published on 13 Oct 2021

Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients

in Hematologic Malignancies

Yan Huang
Minghua Hong
Zhigang Qu
Weiyan Zheng
Huixian Hu
Linjie Li
Ting Lu
Ying Xie
Shuangwei Ying
Yuanyuan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.741341

3,913 views
1 citation

Original Research

Published on 13 Oct 2021

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1

in Hematologic Malignancies

Yang Xiao
Jinghong Chen
Jia Wang
Wei Guan
Mengzhen Wang
Linlin Zhang
Zhiding Wang
Lixin Wang
Li Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.751834

4,570 views
17 citations

Original Research

Published on 12 Oct 2021

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression

in Hematologic Malignancies

Wenwen Zhang
Qian Ma
Bing Long
Zhangyi Sun
Lingling Liu
Dongjun Lin
Minyi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.725336

6,789 views
14 citations

Original Research

Published on 12 Oct 2021

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

in Hematologic Malignancies

Silvia Valtorta
Denise Toscani
Martina Chiu
Andrea Sartori
Angela Coliva
Arianna Brevi
Giuseppe Taurino
Matteo Grioni
Livia Ruffini
Federica Vacondio

Frontiers in Oncology

doi 10.3389/fonc.2021.760732

6,277 views
12 citations

Case Report

Published on 11 Oct 2021

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

in Hematologic Malignancies

Yingxin Sun
Yifeng Cai
Jia Chen
Jiannong Cen
Mingqing Zhu
Jinlan Pan
Depei Wu
Aining Sun
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.753842

5,507 views
5 citations

Original Research

Published on 08 Oct 2021

Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia

in Hematologic Malignancies

Chaofeng Liang
Yujie Zhao
Cunte Chen
Shuxin Huang
Tairan Deng
Xiangbo Zeng
Jiaxiong Tan
Xianfeng Zha
Shaohua Chen
Yangqiu Li

Frontiers in Oncology

doi 10.3389/fonc.2021.740642

7,401 views
21 citations

Original Research

Published on 08 Oct 2021

Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis

in Hematologic Malignancies

Mohammad B. Aljazi
Yuen Gao
Yan Wu
George I. Mias
Jin He

Frontiers in Oncology

doi 10.3389/fonc.2021.754093

7,737 views
14 citations

Systematic Review

Published on 07 Oct 2021

Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation Is a Good Choice for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis of Randomized Controlled Trials

in Hematologic Malignancies

Yanzhi Song
Zhichao Yin
Jie Ding
Tong Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.708727

6,695 views
9 citations

Review

Published on 06 Oct 2021

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

in Hematologic Malignancies

Giuseppe A. Palumbo
Sara Galimberti
Wilma Barcellini
Daniela Cilloni
Nicola Di Renzo
Elena Maria Elli
Carlo Finelli
Luca Maurillo
Alessandra Ricco
Pellegrino Musto

Frontiers in Oncology

doi 10.3389/fonc.2021.752192

10,621 views
16 citations

Review

Published on 01 Oct 2021

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias

in Hematologic Malignancies

Marcin Jasiński
Jarosław Biliński
Grzegorz W. Basak

Frontiers in Oncology

doi 10.3389/fonc.2021.741376

6,439 views
11 citations

Review

Published on 30 Sep 2021

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor

in Hematologic Malignancies

Nicola Sgherza
Paola Curci
Rita Rizzi
Pellegrino Musto

Frontiers in Oncology

doi 10.3389/fonc.2021.716751

6,666 views
2 citations

Original Research

Published on 30 Sep 2021

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

in Hematologic Malignancies

Marie Pajiep
Cécile Conte
Françoise Huguet
Martin Gauthier
Fabien Despas
Maryse Lapeyre-Mestre

Frontiers in Oncology

doi 10.3389/fonc.2021.675609

4,104 views
11 citations

Case Report

Published on 30 Sep 2021

Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia

in Hematologic Malignancies

Samantha Bruno
Lorenza Bandini
Agnese Patuelli
Valentina Robustelli
Claudia Venturi
Manuela Mancini
Dorian Forte
Sara De Santis
Cecilia Monaldi
Alessandra Grassi

Frontiers in Oncology

doi 10.3389/fonc.2021.728613

4,867 views
6 citations

Systematic Review

Published on 30 Sep 2021

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches

in Hematologic Malignancies

Klaus Geissler

Frontiers in Oncology

doi 10.3389/fonc.2021.751668

7,455 views
8 citations

Review

Published on 30 Sep 2021

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies

in Hematologic Malignancies

Hanadi El Achi
Rashmi Kanagal-Shamanna

Frontiers in Oncology

doi 10.3389/fonc.2021.748250

16,424 views
14 citations

Review

Published on 30 Sep 2021

TIM-3 in Leukemia; Immune Response and Beyond

in Hematologic Malignancies

Mahnaz Rezaei
Jiaxiong Tan
Chengwu Zeng
Yangqiu Li
Mazdak Ganjalikhani-Hakemi

Frontiers in Oncology

doi 10.3389/fonc.2021.753677

15,901 views
56 citations

Original Research

Published on 28 Sep 2021

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells

in Hematologic Malignancies

Luciana Yamamoto de Almeida
Diego A. Pereira-Martins
Isabel Weinhäuser
César Ortiz
Larissa A. Cândido
Ana Paula Lange
Nayara F. De Abreu
Sílvia E. S. Mendonza
Virgínia M. de Deus Wagatsuma
Mariane C. Do Nascimento

Frontiers in Oncology

doi 10.3389/fonc.2021.686445

6,341 views
14 citations

Review

Published on 28 Sep 2021

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism

in Hematologic Malignancies

Guangjie Zhao
Qian Wang
Shuang Li
Xiaoqin Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.706030

9,397 views
24 citations

Original Research

Published on 28 Sep 2021

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

in Hematologic Malignancies

Marco Capecchi
Fabio Serpenti
Juri Giannotta
Loredana Pettine
Gianluigi Reda
Ida Martinelli
Andrea Artoni
Wilma Barcellini
Bruno Fattizzo

Frontiers in Oncology

doi 10.3389/fonc.2021.680411

7,100 views
9 citations

Original Research

Published on 27 Sep 2021

Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT

in Hematologic Malignancies

Tongtong Zhang
Xiebing Bao
Huiying Qiu
Xiaowen Tang
Yue Han
Chengcheng Fu
Aining Sun
Changgeng Ruan
Depei Wu
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.732088

3,664 views
4 citations

Original Research

Published on 27 Sep 2021

Detection of Metastatic Tumor Cells in the Bone Marrow Aspirate Smears by Artificial Intelligence (AI)-Based Morphogo System

in Hematologic Malignancies

Pu Chen
Run Chen Xu
Nan Chen
Lan Zhang
Li Zhang
Jianfeng Zhu
Baishen Pan
Beili Wang
Wei Guo

Frontiers in Oncology

doi 10.3389/fonc.2021.742395

10,728 views
26 citations

Mini Review

Published on 24 Sep 2021

Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies

in Hematologic Malignancies

Deeksha Mehtani
Niti Puri

Frontiers in Oncology

doi 10.3389/fonc.2021.731323

3,441 views
5 citations

Review

Published on 23 Sep 2021

A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Víctor Arenas
Jose Luis Castaño
Juan José Domínguez-García
Lucrecia Yáñez
Carlos Pipaón

Frontiers in Oncology

doi 10.3389/fonc.2021.729550

4,146 views
7 citations

2,059 articles

articles

GSTT1null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients

Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia

Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis

Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation Is a Good Choice for Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis of Randomized Controlled Trials

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies

TIM-3 in Leukemia; Immune Response and Beyond

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT

Detection of Metastatic Tumor Cells in the Bone Marrow Aspirate Smears by Artificial Intelligence (AI)-Based Morphogo System

Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies

A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia